AU2001236733A1 - Fas pathway genes - Google Patents
Fas pathway genesInfo
- Publication number
- AU2001236733A1 AU2001236733A1 AU2001236733A AU3673301A AU2001236733A1 AU 2001236733 A1 AU2001236733 A1 AU 2001236733A1 AU 2001236733 A AU2001236733 A AU 2001236733A AU 3673301 A AU3673301 A AU 3673301A AU 2001236733 A1 AU2001236733 A1 AU 2001236733A1
- Authority
- AU
- Australia
- Prior art keywords
- pathway genes
- fas pathway
- fas
- genes
- pathway
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49955300A | 2000-02-07 | 2000-02-07 | |
US09/499,553 | 2000-02-07 | ||
PCT/US2001/003946 WO2001057189A2 (en) | 2000-02-07 | 2001-02-07 | Fas pathway genes |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001236733A1 true AU2001236733A1 (en) | 2001-08-14 |
Family
ID=23985704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001236733A Abandoned AU2001236733A1 (en) | 2000-02-07 | 2001-02-07 | Fas pathway genes |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU2001236733A1 (en) |
GB (1) | GB2375172A (en) |
IL (1) | IL151079A0 (en) |
WO (1) | WO2001057189A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002364889A1 (en) * | 2001-09-24 | 2003-06-10 | University Of Aarhus | Methods for diagnosis and treatment of diseases associated with altered expression of nrf2 |
DE10147088A1 (en) * | 2001-09-25 | 2003-04-17 | Medinnova Ges Med Innovationen | Use of active substances for the prophylaxis and / or therapy of diseases which are associated with cell growth disorders and test system for finding such active substances |
FR2853911B1 (en) * | 2003-04-17 | 2005-07-08 | Merck Sante Sas | INSULIN-INDUCED GENE AS A THERAPEUTIC TARGET IN DIABETES |
WO2005046726A2 (en) * | 2003-11-12 | 2005-05-26 | Allergan, Inc. | Combinations for inhibiting cell growth which contains an inhibitor of human ck1 alpha activity and a rxr agonist |
NZ564762A (en) * | 2005-05-26 | 2011-10-28 | Univ Johns Hopkins | Compositions and methods for the treatment or prevention of chemoresistant neoplasia |
CA2937992A1 (en) * | 2014-02-03 | 2015-08-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Method of eliminating stem cells |
JP2021513861A (en) | 2018-02-21 | 2021-06-03 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | CAMK2D antisense oligonucleotide and its use |
CN111671749A (en) * | 2020-06-12 | 2020-09-18 | 重庆医科大学 | Application of dicoumarol in preparation of HBx protein stability inhibitor |
CN112121043A (en) * | 2020-10-27 | 2020-12-25 | 澳门大学 | Application of dicoumarol in antitumor |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994026933A1 (en) * | 1993-05-13 | 1994-11-24 | The Board Of Trustees Of The Leland Stanford Junior University | Genetic footprinting: insertional mutagenesis and genetic selection |
-
2001
- 2001-02-07 AU AU2001236733A patent/AU2001236733A1/en not_active Abandoned
- 2001-02-07 WO PCT/US2001/003946 patent/WO2001057189A2/en active Search and Examination
- 2001-02-07 GB GB0219775A patent/GB2375172A/en not_active Withdrawn
- 2001-02-07 IL IL15107901A patent/IL151079A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001057189A2 (en) | 2001-08-09 |
GB2375172A (en) | 2002-11-06 |
WO2001057189A3 (en) | 2002-05-02 |
IL151079A0 (en) | 2003-04-10 |
WO2001057189A9 (en) | 2002-10-24 |
GB0219775D0 (en) | 2002-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001262847A1 (en) | Language-understanding | |
AU2001292739A1 (en) | 1-oxorapamycins | |
AU2001254546A1 (en) | Aminopiperidines | |
AU2000267458A1 (en) | Hypercomputer | |
AU2001239310A1 (en) | Decahydro-isoquinolines | |
AU2001220246A1 (en) | Neckphone | |
AU2002211620A1 (en) | Autoanastomosis | |
AU2001258349A1 (en) | Bisacylguanidine | |
AU2001296577A1 (en) | Chlorophyllases | |
AU2001279754A1 (en) | Indoloquinazolinones | |
AU2002211128A1 (en) | Step-bike | |
AU2001285886A1 (en) | 2-guanidino-4-aryl-quinazoline | |
AU2001290931A1 (en) | Ski-snowboard | |
AU2001258924A1 (en) | Microsatellite-aflp | |
AU2001293852A1 (en) | Sulfonylguanidine | |
AU2002226346A1 (en) | 2-aryl-5-trifluoromethylpyridines | |
AU2001236733A1 (en) | Fas pathway genes | |
AU2001242625A1 (en) | Gene sequence | |
AU2001240103A1 (en) | Reproduction-specific genes | |
AU2001264247A1 (en) | GASC1 gene | |
AU2001281921A1 (en) | Bdellosomes | |
AU2001291876A1 (en) | Triazolo-epothilones | |
AU2001246864A1 (en) | Hypotensors | |
AUPQ749100A0 (en) | New epilespy gene | |
AU2001247444A1 (en) | Erbeta-mediated gene expression |